# Vaccination Against High Risk Breast Cancer Using Tumor Derived Heat Shock Protein 70

> **NCT00027131** · PHASE1,PHASE2 · TERMINATED · sponsor: **UConn Health** · enrollment: 15 (—)

## Conditions studied

- Breast Neoplasms

## Interventions

- **BIOLOGICAL:** Heat Shock Protein 70-peptide complexes (HSP70)

## Key facts

- **NCT ID:** NCT00027131
- **Lead sponsor:** UConn Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2000-12
- **Primary completion:** —
- **Final completion:** 2002-10
- **Target enrollment:** 15 (—)
- **Why stopped:** difficulty with accrual
- **Last updated:** 2008-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00027131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00027131, "Vaccination Against High Risk Breast Cancer Using Tumor Derived Heat Shock Protein 70". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00027131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*